The 2 newest Alzheimer’s drugs, Leqembi (lecanemab) and Kisunla (donanemab) show promise, but many questions remain. Here are the three next ones.
Right now, there are two FDA approved drugs to treat Alzheimer’s itself. Find out why Remternetug may soon get approval as a third, even better treatment.
Kisunla, the newest Alzheimer’s drug, is rapidly gaining acceptance around the world. Learn what it does and how to get it.
How do the new drugs Leqembi and Kisunla fight Alzheimer’s? Surprisingly, increases in amyloid-beta protein levels can explain the slowing of Alzheimer’s at least as well as the reduction in amyloid plaques.
Dr. Jason Karlawish from Penn Memory Center discusses the careful process of determining if Lecanemab is right for a patient with Alzheimer’s.
Ely Lilly unveils new $1,000,000,000 facility for drugs including Kisunla for Alzheimer’s. New investment will enhance global medicine production, benefiting millions of patients worldwide
In a new Alzheimer’s study, Rexulti (brexpiprazole) significantly reduced agitation. Learn the kinds of agitation it reduced and by how much.
There are no approved treatments for DLB, though it is the second most common type of dementia. Do drugs like donepezil hold the key?
While the initial headlines might seem discouraging, there’s always more to the story. 🌟
The newest Alzheimer’s drugs, Kisunla and Leqembi, are the first to actually slow down Alzheimer’s. How do they compare to each other?
Creating peace, calm and a sense of control over their environment is the best gift to give a person living with Alzheimer’s. Learn all about In-Home Routines.
Cardiovascular events like strokes can trigger vascular dementia.American Heart Association cholesterol guidelines can significantly reduce cardiovascular events. Is it time to take a fresh look at your cholesterol?
VIDEO If you live to 85, there’s a 50/50 chance of getting a dementia such as Alzheimer’s. What if you could improve those odds by
The “glymphatic system” removes brain waste. It may be a powerful new target to treat Alzheimer’s. Learn why scientists believe Alzheimer’s may arise when the system is not doing its cleaning properly.
Plaques are the best-known Alzheimer’s culprit. Cambridge scientists have figured out the 7 steps to forming these plaques. Find out how targeting the formation of these “oligomers” may hold the key to a cure.
UCLA researchers found active people build 5% more gray matter in their brain. See how this prevents Alzheimer’s.
Learn about The Alzheimer’s Society of Canada’s campaign to bust the stigma of dementia.
Discover 6 easy ways you can make a difference.
No spam, only news and updates.
